Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumor therapy with monoclonal antibodies.

× No keyword cloud information.

22 in total

1. Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccines.

Authors: Gregory Kanter; Junhao Yang; Alexei Voloshin; Shoshana Levy; James R Swartz; Ronald Levy
Journal: Blood Date: 2006-12-12 Impact factor: 22.113

2. Peptides and proteins as drugs.

Authors: B L Ferraiolo; L Z Benet
Journal: Pharm Res Date: 1985-07 Impact factor: 4.200

Review 3. Immunoconjugates: applications in targeted drug delivery for cancer therapy.

Authors: B P Ram; P Tyle
Journal: Pharm Res Date: 1987-06 Impact factor: 4.200

4. In vivo efficacy of monoclonal antibody-drug conjugates of three different subisotypes which bind the human tumor-associated antigen defined by the KS1/4 monoclonal antibody.

Authors: J J Starling; R S Maciak; N A Hinson; C L Nichols; S L Briggs; B C Laguzza
Journal: Cancer Immunol Immunother Date: 1989 Impact factor: 6.968

5. Mechanism of recovery from acute virus infection: treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response.

Authors: D Moskophidis; S P Cobbold; H Waldmann; F Lehmann-Grube
Journal: J Virol Date: 1987-06 Impact factor: 5.103

6. Monoclonal antibodies: technology and application to gram-negative infections.

Authors: L S Young
Journal: Infection Date: 1985 Impact factor: 3.553

7. Detection of retroviral particles in hybridomas secreting monoclonal antibodies.

Authors: A H Bartal; C Feit; R A Erlandson; Y Hirshaut
Journal: Med Microbiol Immunol Date: 1986 Impact factor: 3.402

8. Monoclonal antibodies to Lewis lung carcinoma.

Authors: S Ukei; I Saiki; I Azuma
Journal: J Cancer Res Clin Oncol Date: 1985 Impact factor: 4.553

Review 9. New perspectives of secondary and tertiary therapy for rheumatoid arthritis.

Authors: R F Willkens
Journal: Drugs Date: 1989-05 Impact factor: 9.546

10. Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?

Authors: H Koprowski; D Herlyn; M Lubeck; E DeFreitas; H F Sears
Journal: Proc Natl Acad Sci U S A Date: 1984-01 Impact factor: 11.205